The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Zhaofeng ShiChen ZhaoJiayuan HuQianqian DaiManke GuanChangming ZhongGui-Hua TianHong-Cai ShangPublished in: Evidence-based complementary and alternative medicine : eCAM (2020)
TCMI with the effect of Liqihuoxue or Yiqihuoxue combined with western medicine generally showed the potential advantage on the treatment of ACS during the perioperative period of PCI. However, the optimal time point of intervention and recommended plan based on the effect still needs more clinical evidence. We consider that the research of precise and standardized application of TCMI will be a promising direction for TCM in the future.
Keyphrases
- percutaneous coronary intervention
- acute coronary syndrome
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- antiplatelet therapy
- coronary artery disease
- cardiac surgery
- patients undergoing
- randomized controlled trial
- coronary artery bypass grafting
- atrial fibrillation
- current status
- south africa
- coronary artery bypass
- acute kidney injury
- risk assessment
- human health
- left ventricular